How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?

Détails

ID Serval
serval:BIB_0578CC8A5669
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Périodique
Journal of cardiothoracic and vascular anesthesia
Auteur⸱e⸱s
Koster A., Erdoes G., Nagler M., Birschmann I., Alberio L.
ISSN
1532-8422 (Electronic)
ISSN-L
1053-0770
Statut éditorial
Publié
Date de publication
06/2021
Peer-reviewed
Oui
Volume
35
Numéro
6
Pages
1585-1593
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
The aim of this article is to provide a comprehensive review of the current state of knowledge on heparin-induced thrombocytopenia (HIT) in cardiac surgery. The management of HIT patients undergoing cardiac surgery with cardiopulmonary bypass is complex and requires an interdisciplinary and patient-tailored approach because available evidence is limited and current anticoagulation strategies have potential risks. An index case is used to discuss both the established and new perioperative therapeutic options in HIT patients undergoing urgent cardiac surgery with cardiopulmonary bypass.
Mots-clé
Anticoagulants/adverse effects, Cardiac Surgical Procedures/adverse effects, Cardiopulmonary Bypass/adverse effects, Heparin/adverse effects, Humans, Thrombocytopenia/chemically induced, FcγRIIa receptor polymorphism, cardiac surgery, heparin-induced thrombocytopenia, immune complexes, intravenous polyvalent immunoglobulin, non-heparin–based anticoagulation
Pubmed
Web of science
Création de la notice
23/02/2021 16:42
Dernière modification de la notice
21/10/2021 5:40
Données d'usage